肺癌病人化療期間疲憊、睡眠障礙及情緒困擾之探討

Fatigue, Sleep Disturbances, and Mood Distress in Patients with Lung Cancer during Chemotherapy

周繡玲(Hsiu-Ling Chou) ； 姚鍾太(Chung-Tay Yao) ； 楊立華(Luke Yang) ； 朱基銘(Chi-Ming Chu) ； 趙婉青(Wan-Ching Chao)

《腫瘤護理雜誌》 10卷2期 (2010/12) Pp. 23-38

https://doi.org/10.6880/TJON.201012_10(2).03

摘要

Fatigue, sleep disturbances, and mood distress are common problems among the lung cancer patients who have received chemotherapy. The purposes of this study were to follow the changes of the levels of fatigue, sleep disturbances, and mood distress, that were measured at 3 time points: before the first chemotherapy, day 8 after first chemotherapy, and before the second chemotherapy. The study explored the relationships between fatigue and sleep disturbances, or mood distress, and the effects of the variables and fatigue in lung cancer patients who were receiving chemotherapy. The General Fatigue Scale, Pittsburgh Sleep Quality Index, Short Form Profile of Mood States-anxiety and depression subscale were used to measure fatigue, sleep disturbances, and mood distress sequentially. Descriptive, repeated measures, and correlational statistics were used to evaluate data. A total of 75 lung cancer participants were recruited into this study. There were significant differences over time in the changes of fatigue, sleep disturbances, anxiety and depression scores (p＜0.01). Gender had a significant over time effect on sleep disturbances, anxiety and depression scores (p＜0.01). Female patients reported more sleep disturbances, anxiety, and depression than male patients. There was a moderately strong correlation fatigue, sleep disturbances, anxiety and depression. It is expected that these findings can serve as important evidence to guide clinical nurses in the care of the cancer patients with fatigue, sleep disturbances, and mood distress during the course of chemotherapy, and improve the quality of care and strategies to manage fatigue for lung cancer patients undergoing chemotherapy.

關鍵字

肺癌病人 ； 疲憊 ； 睡眠障礙 ； 情緒困擾 ； 化學治療

並列摘要

Fatigue, sleep disturbances, and mood distress are common problems among the lung cancer patients who have received chemotherapy. The purposes of this study were to follow the changes of the levels of fatigue, sleep disturbances, and mood distress, that were measured at 3 time points: before the first chemotherapy, day 8 after first chemotherapy, and before the second chemotherapy. The study explored the relationships between fatigue and sleep disturbances, or mood distress, and the effects of the variables and fatigue in lung cancer patients who were receiving chemotherapy. The General Fatigue Scale, Pittsburgh Sleep Quality Index, Short Form Profile of Mood States-anxiety and depression subscale were used to measure fatigue, sleep disturbances, and mood distress sequentially. Descriptive, repeated measures, and correlational statistics were used to evaluate data. A total of 75 lung cancer participants were recruited into this study. There were significant differences over time in the changes of fatigue, sleep disturbances, anxiety and depression scores (p＜0.01). Gender had a significant over time effect on sleep disturbances, anxiety and depression scores (p＜0.01). Female patients reported more sleep disturbances, anxiety, and depression than male patients. There was a moderately strong correlation fatigue, sleep disturbances, anxiety and depression. It is expected that these findings can serve as important evidence to guide clinical nurses in the care of the cancer patients with fatigue, sleep disturbances, and mood distress during the course of chemotherapy, and improve the quality of care and strategies to manage fatigue for lung cancer patients undergoing chemotherapy.

並列關鍵字

lung cancer ； fatigue ； sleep disturbances ； mood distress ； chemotherapy